Jump to Navigation
Trends and Sentiments
Comments and Analysis
Can A Restaurant Slump Trigger A U.S. Recession?
What Is Truly Left Of The 'Recovery'
Best Near-Term Price Gains Ahead For: Leveraged-Long ETFs
Donald Trump's $10 Minimum Wage Isn't A Good...
Ford Witnesses Worst Daily Loss in Five Years
Dollar General is profiting from Walmart's failure
These 30 Fortune 500 companies have the most cash in off-...
We saw these brand new Tesla Model Xs parked outside...
BA owner IAG's profits hit by weak pound
VW's Audi says emissions, Takata costs weigh down...
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
These 30 Fortune 500 companies have the most cash...
We saw these brand new Tesla Model Xs parked...
EUR/GBP: 1.1876 USD/EUR: 1.1089 JPY/USD: 103.6290
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions